Porcine intestinal mucosal heparin induced aggregation of platelets in citrated platelet-rich plasma and enhanced platelet aggregation and serotonin secretion induced by other agents. This action of heparin was blocked by substances that elevate platelet cyclic AMP and by EDTA but not by inhibitors of platelet cyclooxygenase. The effect was not inhibited by apyrase or by N-amylthio-5′-AMP and therefore did not require the action of ADP, nor was there activation of platelet phospholipase. Platelet aggregation by heparin required a plasma cofactor different from the cofactor required for ristocetin.
Edwin W. Salzman, Robert D. Rosenberg, Marianne H. Smith, Jack N. Lindon, Leonard Favreau
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1974 | 1973 | 1949 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 4 | 1 | 1 | 2 | 1 | 5 | 3 | 3 | 3 | 2 | 5 | 9 | 10 | 4 | 8 | 5 | 7 | 9 | 4 | 5 | 10 | 9 | 8 | 17 | 14 | 17 | 14 | 15 | 14 | 18 | 11 | 11 | 22 | 19 | 18 | 19 | 17 | 30 | 18 | 21 | 12 | 18 | 13 | 8 | 1 | 1 | 1 | 1 | 469 |
Title and authors | Publication | Year |
---|---|---|
Multifunctional Slippery Nanoemulsion-Infused Porous Nitric Oxide-Releasing Surfaces
Nguyen GH, Garren M, Wu Y, Mondal A, Handa H, Brisbois EJ |
Journal of colloid and interface science | 2025 |
Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.
Raner G, Hu Y, Trowbridge C, Zhang L, Logan J, Wu X, Zhang X |
Cureus | 2024 |
Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
De Luca G, Verburg A, Hof AV, ten Berg J, Kereiakes DJ, Coller BS, Gibson CM |
Biomedicines | 2024 |
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points
Gouin-Thibault I, Mansour A, Hardy M, Guéret P, de Maistre E, Siguret V, Cuker A, Mullier F, Lecompte T |
TH Open: Companion Journal to Thrombosis and Haemostasis | 2024 |
Imaging flow cytometry as a novel approach for the diagnosis of heparin‐induced thrombocytopenia
Carré J, Demont Y, Mouton C, Vayne C, Guéry E, Voyer A, Garçon L, Le Guyader M, Demagny J |
British Journal of Haematology | 2024 |
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
Rikken SAOF, van 't Hof AWJ, Ten Berg JM, Kereiakes DJ, Coller BS |
Journal of the American Heart Association | 2023 |
Effects of ex vivo blood anticoagulation and preanalytical processing time on the proteome content of platelets
Yunga ST, Gower AJ, Melrose AR, Fitzgerald MK, Rajendran A, Lusardi TA, Armstrong RJ, Minnier J, Jordan KR, McCarty OJ, David LL, Wilmarth PA, Reddy AP, Aslan JE |
Journal of Thrombosis and Haemostasis | 2022 |
Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta
S Zullino, S Clemenza, F Mecacci, F Petraglia |
Reproductive sciences (Thousand Oaks, Calif.) | 2021 |
Heparin and Derivatives for Advanced Cell Therapies
S Laner-Plamberger, M Oeller, E Rohde, K Schallmoser, D Strunk |
International journal of molecular sciences | 2021 |
Electroconductive Graphene-Containing Polymeric Patch: A Promising Platform for Future Cardiac Repair
A Talebi, S Labbaf, F Karimzadeh, E Masaeli, MH Esfahani |
ACS Biomaterials Science & Engineering | 2020 |
Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B
T Vögtle, S Sharma, J Mori, Z Nagy, D Semeniak, C Scandola, MJ Geer, CW Smith, J Lane, S Pollack, R Lassila, A Jouppila, AJ Barr, DJ Ogg, TD Howard, HJ McMiken, J Warwicker, C Geh, R Rowlinson, WM Abbott, A Eckly, H Schulze, GJ Wright, A Mazharian, K Fütterer, S Rajesh, MR Douglas, YA Senis |
eLife | 2019 |
Shear-induced platelet aggregation: 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis
MT Griffin, D Kim, DN Ku |
Biomicrofluidics | 2019 |
Assessing the Thrombogenic Potential of Heart Valve Prostheses: An Approach for a Standardized In-Vitro Method
T Linde, J Clauser, B Meuris, U Steinseifer |
Cardiovascular Engineering and Technology | 2019 |
From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation
G Spadarella, AD Minno, MB Donati, M Mormile, I Ventre, GD Minno |
Blood Reviews | 2019 |
Antithrombotic, antimicrobial activities, and biocompatibility of surface-functionalized titanium
G Zhang, X Zhang, Z Sun, X Yao, X Zhang |
Journal of Materials Research | 2019 |
VV extracorporeal life support for the Third Millennium: will we need anticoagulation?
D Eytan, Y Bitterman, GM Annich |
Journal of Thoracic Disease | 2018 |
Blood loss of total knee arthroplasty in osteoarthritis: an analysis of influential factors
Y Hu, Q Li, BG Wei, XS Zhang, TT Torsha, J Xiao, ZJ Shi |
Journal of orthopaedic surgery and research | 2018 |
Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits
A Ontaneda, GM Annich |
Frontiers in Medicine | 2018 |
Platelets in Thrombotic and Non-Thrombotic Disorders
P Gresele, NS Kleiman, JA Lopez, CP Page |
Platelets in Thrombotic and Non-Thrombotic Disorders | 2017 |
Biomimetic Heparan Sulfate-Like Coated ePTFE Grafts Reduce In-graft Neointimal Hyperplasia in Ovine Carotids
B Wulff, S Stahlhoff, R Vonthein, A Schmidt, M Sigler, GB Torsello, M Herten |
Annals of Vascular Surgery | 2017 |
Hemodynamic studies of platelet thrombosis using microfluidics
SM Hastings, MT Griffin, DN Ku |
Platelets | 2017 |
Advances in Experimental Medicine and Biology
FS Sharif-Askari, SA Sulaiman, NS Sharif-Askari |
Advances in experimental medicine and biology | 2016 |
Microfluidics for simultaneous quantification of platelet adhesion and blood viscosity
E Yeom, JH Park, YJ Kang, SJ Lee |
Scientific Reports | 2016 |
Vitrectomy for Proliferative Diabetic Retinopathy in a Patient with Heparin-Induced Thrombocytopenia
T Fujii, M Akashi, S Morishita, M Fukumoto, H Suzuki, T Kobayashi, T Kida, M Kagitani, I Morino, T Ikeda |
Case Reports in Ophthalmology | 2016 |
Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: Inhibition of anticoagulant activity by low molecular weight heparin
S Dutta, D Gogoi, AK Mukherjee |
Biochimie | 2015 |
Aspirin and heparin in pregnancy
E Grandone, M Villani, GL Tiscia |
Expert Opinion on Pharmacotherapy | 2015 |
Zastosowanie koncentratu czynników zespołu protrombiny w leczeniu zaburzeń hemostazy osoczowej po operacji transplantacji serca
T Urbanowicz, M Puślecki, W Budniak, P Buczkowski, J Tomczyk, M Walczak, M Ligowski, I Katyńska, M Jemielity |
Acta Haematologica Polonica | 2013 |
Ex Vivo Lung Evaluation of Prearrest Heparinization in Donation After Cardiac Death:
PG Sanchez, GJ Bittle, K Williams, C Pasrija, K Xu, X Wei, ZJ Wu, BP Griffith |
Annals of Surgery | 2013 |
Retina
G Staurenghi, F Bottoni, A Giani |
Retina | 2013 |
Anesthetic Pharmacology and Physiology
D Royston |
Anesthetic Pharmacology and Physiology | 2013 |
The antineoplastic effect of low-molecular-weight heparins - a literature review
J Bochenek, M Püsküllüoğlu, K Krzemieniecki |
WSPOLCZESNA ONKOL | 2013 |
Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile of the Oral Antiplatelet Agent Ticagrelor :
R Teng |
Clinical Pharmacokinetics | 2012 |
Dacie and Lewis Practical Haematology
F Regan |
Dacie and Lewis Practical Haematology | 2012 |
Advances in Carbohydrate Chemistry and Biochemistry
D Mirelman, EA Bayer, Y Reisner |
Advances in Carbohydrate Chemistry and Biochemistry | 2012 |
Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects: Ticagrelor and enoxaparin/UFH
R Teng, K Butler |
Journal of Clinical Pharmacy and Therapeutics | 2012 |
Pharmacologic Management of Coagulopathy in Cardiac Surgery: An Update
T Rozental, L Shore-Lesserson |
Journal of Cardiothoracic and Vascular Anesthesia | 2012 |
Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser
LR Johnston, PD Larsen, AC la Flamme, SA Harding |
Platelets | 2012 |
Parenteral Anticoagulants
DA Garcia, TP Baglin, JI Weitz, MM Samama |
Chest | 2012 |
Six years of clinical follow-up with endothelial cell–seeded small-diameter vascular grafts during coronary bypass surgery
PM Dohmen, A Pruss, C Koch, AC Borges, W Konertz |
Journal of Tissue Engineering | 2012 |
Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile of the Oral Antiplatelet Agent Ticagrelor:
R Teng |
Clinical Pharmacokinetics | 2012 |
Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling
C Gao, B Boylan, J Fang, DA Wilcox, DK Newman, PJ Newman |
Blood | 2011 |
Gynecologic Oncology
A Vasilev, S Vasilev |
Gynecologic Oncology | 2011 |
Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions
KN Sask, WG McClung, LR Berry, AK Chan, JL Brash |
Acta Biomaterialia | 2011 |
Interventional Cardiology
G Sangiorgi, A Mauriello, S Trimarchi, E Bonanno, LG Spagnoli |
Interventional Cardiology | 2011 |
The artificial endothelium
MM Reynolds, GM Annich |
Organogenesis | 2011 |
Heparin modulates the conformation and signaling of platelet integrin αIIbβ3
M Yagi, J Murray, K Strand, S Blystone, G Interlandi, Y Suda, M Sobel |
Thrombosis Research | 2011 |
Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes
G Chalkiadaki, D Nikitovic, P Katonis, A Berdiaki, A Tsatsakis, I Kotsikogianni, NK Karamanos, GN Tzanakakis |
Cancer Letters | 2011 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Henry's Clinical Diagnosis and Management by Laboratory Methods
JL Miller, AK Rao |
Henry's Clinical Diagnosis and Management by Laboratory Methods | 2011 |
Thoraco-Abdominal Aorta
R Chiesa, G Melissano, A Zangrillo |
2011 | |
Preoperative Heparin Therapy Causes Immune-Mediated Hypotension Upon Heparin Administration for Cardiac Surgery
PA Casthely, V Defilippi, L Cornwell, Z Samuel, T Yoganathan, C Komer, S Cisbarros, A Acevedo |
Journal of Cardiothoracic and Vascular Anesthesia | 2010 |
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: Effects on platelet function in the systemic circulation and across the filter
A Arcangeli, B Rocca, G Salvatori, M Ciancia, RD Cristofaro, M Antonelli |
Thrombosis Research | 2010 |
Improved biocompatibility of thrombo-resistant iron-polysaccharides multilayer coatings on Nitinols
Y Ma, M Liu, X Yue, Z Zha, Z Dai |
International Journal of Biological Macromolecules | 2010 |
Acute Pulmonary Embolism
PD Stein, F Matta |
Current Problems in Cardiology | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Hyperserotonemia in autism: activity of 5HT-associated platelet proteins
D Hranilović, Z Bujas-Petković, M Tomičić, T Bordukalo-Nikšić, S Blažević, L Čičin-Šain |
Journal of Neural Transmission | 2009 |
Self-assembled hemocompatible coating on poly (vinyl chloride) surface
Z Zha, Y Ma, X Yue, M Liu, Z Dai |
Applied Surface Science | 2009 |
Isolation and Characterization of Low Molecular Weight Glycosaminoglycans from Marine Mollusc Amussium pleuronectus (Linne) using Chromatography
R Saravanan, A Shanmugam |
Applied Biochemistry and Biotechnology | 2009 |
Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry
D Bolliger, MD Seeberger, KA Tanaka, S Dell-Kuster, M Gregor, U Zenklusen, M Grapow, DA Tsakiris, M Filipovic |
Platelets | 2009 |
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
AD Blann, CW Khoo |
Vascular Health and Risk Management | 2009 |
Heparin-Induced Thrombocytopenia
E Shantsila, GY Lip, BH Chong |
Chest | 2009 |
Hypothermic cardiopulmonary bypass as a determinant of late thrombocytopenia following cardiac operations in pediatric patients
M Ranucci, C Carlucci, G Isgrò, S Brozzi, A Boncilli, E Costa, A Frigiola |
Acta Anaesthesiologica Scandinavica | 2009 |
Fundamental and Clinical Cardiology Series
PD Stein |
Cardiovascular Disease in the Elderly | 2008 |
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention
D Sibbing, G Busch, S Braun, S Jawansky, A Schomig, A Kastrati, I Ott, N Beckerath |
European Heart Journal | 2008 |
Dacie y Lewis. Hematología Práctica
BJ Bain, N Win |
Dacie y Lewis. Hematología Práctica | 2008 |
Immobilization of heparin: approaches and applications
S Murugesan, J Xie, RJ Linhardt |
Current topics in medicinal chemistry | 2008 |
Parenteral Anticoagulants
J Hirsh, KA Bauer, MB Donati, M Gould, MM Samama, JI Weitz |
Chest | 2008 |
Low-molecular-weight heparin use in acute coronary syndromes and percutaneous coronary interventions: An update
JJ Link, JJ Warner, JA Lemos |
Current Cardiovascular Risk Reports | 2007 |
An in vitro Method for Assessing Biomaterial-Associated Platelet Activation
NG LaFayette, AM Skrzypchak, S Merz, RH Bartlett, GM Annich |
ASAIO Journal | 2007 |
Prevention of perioperative thromboembolism in patients with atrial fibrillation
G Beldi, L Beng, G Siegel, S Bisch-Knaden, D Candinas |
British Journal of Surgery | 2007 |
Regulation of Thrombin Activity—Pharmacologic and Structural Aspects
KA Tanaka, JH Levy |
Hematology/Oncology Clinics of North America | 2007 |
Comparison of Platelet Function and Morphology in Patients Undergoing Percutaneous Coronary Intervention Receiving Bivalirudin Versus Unfractionated Heparin Versus Clopidogrel Pretreatment and Bivalirudin
SX Anand, MC Kim, M Kamran, SK Sharma, AS Kini, J Fareed, DA Hoppensteadt, F Carbon, E Cavusoglu, D Varon, JF Viles-Gonzalez, JJ Badimon, JD Marmur |
The American Journal of Cardiology | 2007 |
An in vitro Method for Assessing Biomaterial-Associated Platelet Activation:
NG LaFayette, AM Skrzypchak, S Merz, RH Bartlett, GM Annich |
ASAIO Journal | 2007 |
Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation
AM Skrzypchak, NG Lafayette, RH Bartlett, Z Zhou, MC Frost, ME Meyerhoff, MM Reynolds, GM Annich |
Perfusion | 2007 |
Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin
SA Harding, JN Din, J Sarma, DH Josephs, KA Fox, DE Newby |
Heart (British Cardiac Society) | 2006 |
Guidelines on the use and monitoring of heparin
T Baglin, TW Barrowcliffe, A Cohen, M Greaves |
British Journal of Haematology | 2006 |
Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock*
LA Kirschenbaum, WC Lopez, P Ohrum, A Tsen, J Khazin, ME Astiz |
Critical Care Medicine | 2006 |
Aspirin reduces platelet aggregation during high-energy excimer laser
R Huang, RB Patel, H Ma, K Taylor, GS Abela |
Lasers in Surgery and Medicine | 2006 |
Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children
L Risch, AR Huber, M Schmugge |
Thrombosis Research | 2006 |
Collection and handling of blood
SM Lewis, N Tatsumi |
Dacie and Lewis Practical Haematology | 2006 |
Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock*:
LA Kirschenbaum, WC Lopez, P Ohrum, A Tsen, J Khazin, ME Astiz |
Critical Care Medicine | 2006 |
Present and Future Anticoagulants
ME Stone, L Shore-Lesserson |
Advances in Anesthesia | 2006 |
Unfractionated Heparin Reduces the Anti-Platelet Effects of Abciximab but not Eptifibatide During PCI
EN Deliargyris, B Upadhya, LG Melton, C Thompson, M Fisher, DA Gabriel, GJ Dehmer, DC Sane |
Clinical and Applied Thrombosis/Hemostasis | 2006 |
Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation
J Kaneko, Y Sugawara, S Tamura, J Togashi, Y Matsui, N Akamatsu, Y Kishi, M Makuuchi |
Clinical Transplantation | 2005 |
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin
RF Storey, JA May, S Heptinstall |
Thrombosis Research | 2005 |
Chemistry and Biology of Heparin and Heparan Sulfate
JM Walenga, WP Jeske, J Fareed |
Chemistry and Biology of Heparin and Heparan Sulfate | 2005 |
Heparin Therapy Leads to Platelet Activation and Prolongation of PFA-100 Closure Time
MS Williams, LS Ngalla |
Journal of cardiovascular pharmacology and therapeutics | 2005 |
Analysis of cellular morphology, adhesion, and proliferation on uncoated and differently coated PVC tubes used in extracorporeal circulation (ECC)
PL Moreira, PR Marreco, AM Moraes, ML Wada, SC Genari |
Journal of Biomedical Materials Research | 2004 |
Acenocoumarol associated priapism: report of a case
S Touloupidis, I Zoumpos, C Kalaitzis, T Vogiatzaki, P Chloropoulou |
Andrologia | 2004 |
Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: Case report and literature review
BR Bendok, DJ Padalino, EI Levy, AI Qureshi, LR Guterman, LN Hopkins |
Surgical neurology | 2004 |
Anticoagulation in Hospitalized Patients With Renal Insufficiency
N Thorevska, Y Amoateng-Adjepong, R Sabahi, I Schiopescu, A Salloum, V Muralidharan, CA Manthous |
Chest | 2004 |
Thrombotic Complications in Three Hemodialysis Patients With Heparin-Induced Thrombocytopenia Type I
S Suzuki, S Sakamoto, M Matsuo, C Shimano, T Kuroda, T Matsuo |
Clinical and Applied Thrombosis/Hemostasis | 2004 |
Characteristics of the hemostatic action of KFA-1411, an inhibitor of coagulation factor Xa (FXa), in humans and various animals
K HARA, T HONMA, A MATSUZAWA, A MATSUZAWA, M UCHIDA, T KOIZUMI, S AKAHANE, M KOJIMA |
The Journal of Toxicological Sciences | 2003 |
Heparin Monitoring in Sheep by Activated Partial Thromboplastin Time
SG Park, SC Kim, MJ Choi, HS Lee, BG Min, J Cheong, K Lee |
Artificial Organs | 2003 |
Platelet responses and coagulation activation on polylactide and heparin-polycaprolactone-L-lactide -coated polylactide stent struts
EM Hietala, P Maasilta, T Välimaa, AL Harjula, P Törmälä, US Salminen, R Lassila |
Journal of Biomedical Materials Research | 2003 |
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation
S Kanemitsu, M Nishikawa, K Onoda, T Shimono, H Shimpo, A Yazaki, K Tanaka, H Shiku, I Yada |
The Journal of Thoracic and Cardiovascular Surgery | 2003 |
Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model
K Yamada, H Tsuji, S Kimura, H Kato, S Yano, N Ukimura, Y Yamada, K Nakagawa, M Nakagawa |
Thrombosis Research | 2003 |
Heparin Modulates Integrin-Mediated Cellular Adhesion: Specificity of Interactions with α and β Integrin Subunits
MS da Silva, JA Horton, JM Wijelath, LW Blystone, WR Fish, E Wijelath, K Strand, SD Blystone, M Sobel |
Cell communication & adhesion | 2003 |
Simultaneous Testing of the Heparin Effect on the Soluble Phase and Platelet Component of Hemostasis
LG Melton, DA Gabriel, GJ Dehmer |
The American Journal of the Medical Sciences | 2003 |
Platelet Loss across the Hemofilter during Continuous Hemofiltration
J Mulder, HK Tan, R Bellomo, W Silvester |
The International Journal of Artificial Organs | 2003 |
Anticoagulation Therapy in Children:
MD Ronghe, C Halsey, NJ Goulden |
Pediatric Drugs | 2003 |
The Hemostatic Defect of Cardiopulmonary Bypass
MD Linden |
Journal of Thrombosis and Thrombolysis | 2003 |
Hypothermia with Heparin-Coated Circuits and Low Dose Systemic Heparinization in Neurosurgery
Y Hachiro, K Morishita, R Koshima, S Nakashima, N Takagi, M Tsukamoto, T Abe, K Hashi |
Artificial Organs | 2002 |
Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates
T Palmerini, MA Nedelman, LE Scudder, MT Nakada, RE Jordan, S Smyth, RE Gordon, JT Fallon, BS Coller |
Journal of the American College of Cardiology | 2002 |
The Low Molecular Weight Heparin, Tinzaparin, in Thrombosis and Beyond
SA Mousa |
Cardiovascular Drug Reviews | 2002 |
A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitro
B Klein, A Faridi, GF Tempelhoff, L Heilmann, C Mittermayer, W Rath |
Thrombosis Research | 2002 |
Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects
J Freedman, MA Mascelli, JC Pezzullo, ES Barnathan, B Frederick, RE Jordan, DR Abernethy |
American Heart Journal | 2002 |
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
M Cohen, P Théroux, S Borzak, MJ Frey, HD White, WV Mieghem, F Senatore, J Lis, R Mukherjee, K Harris, F Bigonzi |
American Heart Journal | 2002 |
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies
CP Walker, D Royston |
British Journal of Anaesthesia | 2002 |
Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases
O-Ki Kwon, Ki Jae Lee, Moon Hee Han, Chang-Wan Oh, Dae Hee Han, Young Cho Koh |
American Journal of Neuroradiology | 2002 |
Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention
Atul Aggarwal, Burton E Sobel, David J Schneider |
Journal of Thrombosis and Thrombolysis | 2002 |
DRUG-INDUCED AND DRUG-DEPENDENT IMMUNE THROMBOCYTOPENIAS
A Greinacher, P Eichler, N Lubenow, V Kiefel |
Reviews in Clinical and Experimental Hematology | 2001 |
Interaction of blood components with heparin-immobilized polyurethanes prepared by plasma glow discharge
IK Kang, EJ Seo, MW Huh, KH Kim |
Journal of Biomaterials Science, Polymer Edition | 2001 |
Heparin modulates integrin function in human platelets
M Sobel, WR Fish, N Toma, S Luo, K Bird, K Mori, S Kusumoto, SD Blystone, Y Suda |
Journal of Vascular Surgery | 2001 |
Tratamiento anticoagulante
ER Hernando, JH Santos, CP Santos, JA Fernández |
Medicine - Programa de Formación Médica Continuada Acreditado | 2001 |
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab
MI Furman, DJ Kereiakes, LA Krueger, MN Mueller, K Pieper, TM Broderick, JF Schneider, WL Howard, ML Fox, MR Barnard, AL Frelinger, AD Michelson |
American Heart Journal | 2001 |
Platelet Adhesion to Heparin Coated Oxygenator Fibers Under In Vitro Static Conditions: Impact of Temperature:
Y Niimi, Y Ishiguro, Y Nakata, T Goto, S Morita, S Yamane |
ASAIO journal (American Society for Artificial Internal Organs : 1992) | 2001 |
Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations
K Kottke-Marchant, S Sapatnekar |
Seminars in cardiothoracic and vascular anesthesia | 2001 |
Guide to Anticoagulant Therapy: Heparin: A Statement for Healthcare Professionals From the American Heart Association
J Hirsh, SS Anand, JL Halperin, V Fuster |
Circulation | 2001 |
Reduction of heparin dose is not beneficial to platelet function
T Nakajima, K Kawazoe, K Ishibashi, Y Kubota, T Sasaki, H Izumoto, T Nitatori |
The Annals of Thoracic Surgery | 2000 |
Albumin and heparin multilayer coatings for blood-contacting medical devices
E Brynda, M Houska, M Jirou?kov�, JE Dyr |
Journal of Biomedical Materials Research | 2000 |
Importance of Uniform Heparin Coating on Biopolymers
PL Moreira, ML Wada, WP Novello |
Artificial Organs | 2000 |
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina
G Montalescot, JP Collet, L Lison, R Choussat, A Ankri, E Vicaut, K Perlemuter, F Philippe, G Drobinski, D Thomas |
Journal of the American College of Cardiology | 2000 |
Assessment of low-molecular-weight heparin trials in cardiology
RI Shulman |
Pharmacology & Therapeutics | 2000 |
Surface characterization and in vitro blood compatibility of poly(ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge
YJ Kim, IK Kang, MW Huh, SC Yoon |
Biomaterials | 2000 |
Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release
KA Mowery, MH Schoenfisch, JE Saavedra, LK Keefer, ME Meyerhoff |
Biomaterials | 2000 |
Platelets
JN George |
The Lancet | 2000 |
Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab
MA Mascelli, NS Kleiman, SJ Marciniak, L Damaraju, HF Weisman, RE Jordan |
American Heart Journal | 2000 |
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions
NS Kleiman, N Grazeiadei, K Maresh, RJ Taylor, B Frederick, ET Lance, MB Effron, RE Jordan, MA Mascelli |
American Heart Journal | 2000 |
The emerging role of low-molecular-weight heparin in cardiovascular medicine
J Hirsh, SM Bates |
Progress in Cardiovascular Diseases | 2000 |
Pharmacokinetics and Pharmacodynamics of Sibrafiban, an Orally Administered GP IIb/IIIa Antagonist, following Coadministration of Aspirin and Heparin
JD Reimann, NB Modi, W Novotny |
The Journal of Clinical Pharmacology | 2000 |
Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers:
GM Annich, JP Meinhardt, KA Mowery, BA Ashton, SI Merz, RB Hirschl, ME Meyerhoff, RH Bartlett |
Critical Care Medicine | 2000 |
Estudo experimental do uso de um antagonista do receptor da glicoproteína IIb/IIIa das placentas na prevenção de tromboses em microanastomoses vasculares
MI Oide |
Acta Ortopédica Brasileira | 2000 |
State-of-the-Art Review : Heparin-Induced Thrombocytopenia: A Critical Risk/Benefit Analysis of Patients in Intensive Care Treated With R-Hirudin
JF Schenk, G Berg, S Mörsdorf, B Stefan, H Kroll, B Krischek, G Pindur, H Schieffer, E Wenzel |
Clinical and Applied Thrombosis/Hemostasis | 2000 |
In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris
PA Merlini, D Ardissino, RD Rosenberg, E Colombi, P Agricola, L Oltrona, F Ottani, M Galvani, KA Bauer, B Bottasso, F Bertocchi, PM Mannucci |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Heparin-Induced Thrombocytopenia: Minimising the Risks in the Elderly Patient
B Tardy-Poncet, B Tardy |
Drugs & Aging | 2000 |
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes
M Cohen, P Théroux, S Weber, P Laramée, T Huynh, S Borzak, JG Diodati, IB Squire, LI Deckelbaum, AR Thornton, KE Harris, FL Sax, MW Lo, HD White |
International Journal of Cardiology | 1999 |
Inhibition of platelet aggregation by the GPIIb/IIIa antagonist Reopro does not significantly prolong xenograft survival in an ex vivo model
AE Fiane, V Videm, TE Mollnes, K Høgåsen, T Hovig |
Transplant International | 1999 |
Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesion
GW Bos, NM Scharenborg, AA Poot, GH Engbers, T Beugeling, WG van Aken, J Feijen |
Journal of Biomedical Materials Research | 1999 |
Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis
MD Shaieb, BN Watson, RE Atkinson |
The Journal of Arthroplasty | 1999 |
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice
AS Dunn, B Coller |
The American Journal of Medicine | 1999 |
Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin
ED Candia, RD Cristofaro, R Landolfi |
Circulation | 1999 |
Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction
M Ferrario, PA Merlini, S Lucreziotti, A Poli, F Cantù, G Gobbi, E Bramucci, A Mussini, D Ardissino |
International Journal of Cardiology | 1999 |
Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation
D Saltissi, C Morgan, J Westhuyzen, H Healy |
Nephrology Dialysis Transplantation | 1999 |
Heparin-Induced Thrombocytopenia: Historical Review
HL Messmore |
Clinical and Applied Thrombosis/Hemostasis | 1999 |
The Effects of Heparin Coating of Oxygenator Fibers on Platelet Adhesion and Protein Adsorption:
Y Niimi, F Ichinose, Y Ishiguro, K Terui, S Uezono, S Morita, S Yamane |
Anesthesia & Analgesia | 1999 |
A single dose of dalteparin effectively prevents clotting during haemodialysis
S Sagedal, A Hartmann, K Sundstrøm, S Bjørnsen, P Fauchald, F Brosstad |
Nephrology Dialysis Transplantation | 1999 |
Hämostaseologie
G Müller-Berghaus, B Pötzsch |
Hämostaseologie | 1999 |
Antithrombotics
AC Uprichard, KP Gallagher |
1999 | |
Die Venenthrombose
V Hach-Wunderle, W Theiss |
1999 | |
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents
A Koenig, K Norgard-Sumnicht, R Linhardt, A Varki |
Journal of Clinical Investigation | 1998 |
Micro stent implantation in patients with acute myocardial infarction without anticoagulation: Clinical experience with two different antithrombotic protocols
PV Oemrawsingh, MJ Schalij, W Udayachalerm, EE van der Wall, AV Bruschke |
Catheterization and Cardiovascular Diagnosis | 1998 |
Covalent Linkage of Recombinant Hirudin to a Novel Ionic Poly(Carbonate) Urethane Polymer with Protein Binding Sites: Determination of Surface Antithrombin Activity
MD Phaneuf, M Szycher, SA Berceli, DJ Dempsey, WC Quist, FW LoGerfo |
Artificial Organs | 1998 |
UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
GF Pineo, RD Hull |
Medical Clinics of North America | 1998 |
Low molecular weight heparins: current use and indications
MA Quader, LS Stump, BE Sumpio |
Journal of the American College of Surgeons | 1998 |
Heparin-Induced Thrombocytopenia
DB Brieger, KH Mak, K Kottke-Marchant, EJ Topol |
Journal of the American College of Cardiology | 1998 |
Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism
PA Routledge, HG Shetty, JP White, P Collins |
British Journal of Clinical Pharmacology | 1998 |
Pulmonary Embolism
SZ Goldhaber |
New England Journal of Medicine | 1998 |
4 Prevention of venous thromboembolism in general surgery
VV Kakkar, F Lorenzo |
Baillière's Clinical Haematology | 1998 |
Low-molecular-weight heparin for the treatment of venous thromboembolism
J Hirsh |
American Heart Journal | 1998 |
13 Heparin-induced thrombocytopenia: pathophysiology and clinical concerns
A Greinacher |
Baillière's Clinical Haematology | 1998 |
5 Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism
GF Pineo, RD Hull |
Baillière's Clinical Haematology | 1998 |
Heparin and Low-Molecular-Weight Heparin
J Hirsh, TE Warkentin, R Raschke, C Granger, EM Ohman, JE Dalen |
Chest | 1998 |
Therapeutic Concentrations of Heparin Augment Platelet Activation at the Time of Coronary Angiography
TZ Naqvi, PK Shah, PA Ivey, MD Molloy, P Linn, M Linker-Israeli, B Cercek, S Kaul |
Journal of cardiovascular pharmacology and therapeutics | 1998 |
Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
Z Xiao, P Théroux |
Circulation | 1998 |
Low-Molecular-Weight Heparin: A Review of the Results of Recent Studies of the Treatment of Venous Thromboembolism and Unstable Angina
J Hirsh |
Circulation | 1998 |
Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade
MA Mascelli, ET Lance, L Damaraju, CL Wagner, HF Weisman, RE Jordan |
Circulation | 1998 |
Antiplatelet Effect of Ticlopidine After Coronary Stenting
FJ Neumann, M Gawaz, T Dickfeld, A Wehinger, H Walter, R Blasini, A Schömig |
Journal of the American College of Cardiology | 1997 |
Heparin-associated Thrombocytopenia and Thrombosis
TF Slaughter, CS Greenberg |
Anesthesiology | 1997 |
Antithrombotic and Platelet Activating Effects of Heparin in Prevention of Microarterial Thrombosis
B Arnljots, P Dougan, D Bergqvist |
Plastic & Reconstructive Surgery | 1997 |
In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma glow discharge
IK Kang, OH Kwon, MK Kim, YM Lee, YK Sung |
Biomaterials | 1997 |
The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls
JK Burgess, BH Chong |
European Journal of Haematology | 1997 |
Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface
MD Phaneuf, SA Berceli, MJ Bide, WG Quist, FW LoGerfo |
Biomaterials | 1997 |
LOW-MOLECULAR-WEIGHT HEPARIN: Prophylaxis and Treatment of Venous Thromboembolism
GF MD, RD MD |
Annual Review of Medicine | 1997 |
Low-Molecular-Weight Heparins
AJ Wood, JI Weitz |
New England Journal of Medicine | 1997 |
BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE
JM Walenga, WP Jeske, L Bara, MM Samama, J Fareed |
Thrombosis Research | 1997 |
ANTICOAGULANT FUCOIDAN FRACTIONS FROM FUCUS VESICULOSUS INDUCE PLATELET ACTIVATION IN VITRO
J Dürig, T Bruhn, KH Zurborn, K Gutensohn, HD Bruhn, L Béress |
Thrombosis Research | 1997 |
The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery
O Sowade, S Ziemer, B Sowade, W Franke, D Messinger, E Ziebell, P Scigalla, H Warnke |
Journal of Laboratory and Clinical Medicine | 1997 |
Rapid and Simple Platelet Function Assay to Assess Glycoprotein IIb/IIIa Receptor Blockade
BS Coller, D Lang, LE Scudder |
Circulation | 1997 |
Life-Threatening Coagulation Disorders in Critical Care Medicine
V Hach-Wunderle, PP Nawroth |
1997 | |
Low Molecular Weight Heparin(oid)s: Clinical Investigations and Practical Recommendations
MT Nurmohamed, H ten Cate, JW ten Cate |
Drugs | 1997 |
Disorders of platelet function
I Fuse |
Critical Reviews in Oncology/Hematology | 1996 |
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172
MJ Wilhelm, C Schmid, D Kececioglu, T Möllhoff, H Ostermann, HH Scheld |
The Annals of Thoracic Surgery | 1996 |
Diabetic Microangiopathic Hemolytic Anemia and Thrombocytopenia With Antiphospholipid Syndrome
H Morita, T Suwa, H Daidoh, N Takeda, T Ishizuka, K Yasuda |
The American Journal of the Medical Sciences | 1996 |
Inhibition of platelet GPIIbIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival time
SC Robson, VK Young, NS Cook, G Kottirsch, JB Siegel, BA Lesnikoski, D Candinas, DJ White, FH Bach |
Xenotransplantation | 1996 |
Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generation
SC Robson, JB Siegel, BA Lesnikoski, C Kopp, D Candinas, U Ryan, FH Bach |
Xenotransplantation | 1996 |
Changes in membrane glycoproteins of circulating platelets after coronary stent implantation
M Gawaz, FJ Neumann, I Ott, A May, S Rüdiger, A Schömig |
Heart (British Cardiac Society) | 1996 |
Heparin induced thrombocytopenia
M Dryjski, H Dryjski |
European Journal of Vascular and Endovascular Surgery | 1996 |
VARIABLE INFLUENCE OF HEPARIN AND CONTRAST AGENTS ON PLATELET FUNCTION AS ASSESSED BY THE IN VITRO BLEEDING TIME
LG Melton, GJ Dehmer, DA Tate, KM Muga, A Meehan, DA Gabriel |
Thrombosis Research | 1996 |
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
S Siragusa, B Cosmi, F Piovella, J Hirsh, JS Ginsberg |
The American Journal of Medicine | 1996 |
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass
RC Gorman, NP Ziats, AK Rao, N Gikakis, L Sun, MM Khan, N Stenach, S Sapatnekar, V Chouhan, JH Gorman, S Niewiarowski, RW Colman, JM Anderson, LH Edmunds |
The Journal of Thoracic and Cardiovascular Surgery | 1996 |
Effect of Low-Molecular-Weight Heparin (Tinzaparin) and Unfractionated Heparin on Platelet Aggregation
HB Ravn, C Bregengaard, H Vissinger, P Østergaard, J Holst, HK Nielsen, SD Kristensen, SE Husted |
Clinical and Applied Thrombosis/Hemostasis | 1996 |
THROMBIN INHIBITION IN AN EX VIVO MODEL OF PORCINE HEART XENOGRAFT HYPERACUTE REJECTION1:
SC Robson, VK Young, NS Cook, R Metternich, W Kasper-Konig, BA Lesnikoski, RN Pierson, WW Hancock, D Candinas, DJ White, FH Bach |
Transplantation | 1996 |
Management of Deep Vein Thrombosis and Pulmonary Embolism: A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association
J Hirsh, J Hoak |
Circulation | 1996 |
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries: Early Outcome of the Benestent-II Pilot Study
PW Serruys, H Emanuelsson, W van der Giessen, AC Lunn, F Kiemeney, C Macaya, W Rutsch, G Heyndrickx, H Suryapranata, V Legrand, JJ Goy, P Materne, H Bonnier, MC Morice, J Fajadet, J Belardi, A Colombo, E Garcia, P Ruygrok, P de Jaegere, MA Morel |
Circulation | 1996 |
Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin
V Hach-Wunderle, PP Nawroth |
1996 | |
Hit, hitt, and desulfatohirudin: Look before you leap
LH Edmunds |
The Journal of Thoracic and Cardiovascular Surgery | 1995 |
The impact of heparin concentration and activated clotting time monitoring on blood conservation
GJ Despotis, JH Joist, CW Hogue, A Alsoufiev, K Kater, LT Goodnough, SA Santoro, E Spitznagel, M Rosenblum, DG Lappas |
The Journal of Thoracic and Cardiovascular Surgery | 1995 |
Reticulated platelets in uremic patients: Effect of hemodialysis and continuous ambulatory peritoneal dialysis
D Tassies, JC Reverter, A Cases, G Escolar, N Villamor, J López-Pedret, R Castillo, A Ordinas |
American Journal of Hematology | 1995 |
Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia
BK Gupta, MP Savage, AN Brest |
Catheterization and Cardiovascular Diagnosis | 1995 |
A comparison between the use of recombinant hirudin and heparin during hemodialysis
V Wyk, PN Badenhorst, HG Luus, HF Kotzé |
Kidney International | 1995 |
Heparin Immobilized Chitosan - Poly Ethylene Glycol Interpenetrating Network: Antithrombogenicity
MS Beena, T Chandy, CP Sharma |
Artificial Cells, Blood Substitutes and Biotechnology | 1995 |
Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)—A three way cross-over study in healthy volunteers
L Falkon, D Sáenz-Campos, R Antonijoan, S Martín, M Barbanoj, J Fontcuberta |
Thrombosis Research | 1995 |
Heparins
J Hirsh |
Fibrinolysis | 1995 |
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
J Hirsh, CR Raschke, TE Warkentin, JE Dalen, D Deykin, L Poller |
Chest | 1995 |
Laboratory Evaluation of Platelet Dysfunction
RL Bick |
Clinics in Laboratory Medicine | 1995 |
Activated Clotting Time as an Appropriate Test to Compare Heparin and Direct Thrombin Inhibitors Such as Hirudin or Ro 46-6240 in Experimental Arterial Thrombosis
JP Carteaux, A Gast, TB Tschopp, S Roux |
Circulation | 1995 |
Effects of Recombinant Hirudin (r-Hirudin, HBW 023) on Coagulation and Platelet Activation In Vivo: Comparison With Unfractionated Heparin and a Low-Molecular-Weight Heparin Preparation (Fragmin)
S Eichinger, M Wolzt, B Schneider, M Nieszpaur-Los, H Heinrichs, K Lechner, HG Eichler, PA Kyrle |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Cardiopulmonary Bypass
CT Mora, RA Guyton, DC Finlayson, RL Rigatti |
1995 | |
Inhibitory Effect of Clopidogrel, Vapiprost and Argatroban on the Middle Cerebral Artery Thrombosis in the Rat
K Umemura, H Kawai, H Ishihara, M Nakashima |
The Japanese Journal of Pharmacology | 1995 |
Advantageous effect of low-molecular-weight heparin administration on hepatic mitochondrial redox state
H Sasaki, T Yamaguchi, K Kumada, H Higashiyama, M Terasaki, S Mashima, A Mitsuyoshi, M Nakagami, T Morimoto, Y Shimahara, K Ozawa |
Research in Experimental Medicine | 1994 |
Mechanism of action of heparin and heparin-like antithrombotics
ST Olson, I Björk |
Perspectives in Drug Discovery and Design | 1994 |
Benestent II: Back to the Future
H Emanuelsson, WI van der GIESSEN, PW Serruys |
Journal of Interventional Cardiology | 1994 |
Interaction of heparin with synthetic antithrombin III peptide analogues
J Bae, UR Desai, A Pervin, EE Caldwell, JM Weiler, RJ Linhardt |
Biochemical Journal | 1994 |
Deep-Vein Thrombosis
EE Weinmann, EW Salzman |
New England Journal of Medicine | 1994 |
At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects
ME Carr, SL Carr |
Thrombosis Research | 1994 |
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin
R Kijowski, D Hoppensteadt, J Walenga, L Borris, MR Lassen, J Fareed |
Thrombosis Research | 1994 |
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukaemia: A randomised, heparin-controlled pilot study
E Cofrancesco, C Boschetti, P Leonardi, F Gianese, M Cortellaro |
Thrombosis Research | 1994 |
10 Myeloproliferative and metabolic causes
SD Wright, EG Tuddenham |
Baillière's Clinical Haematology | 1994 |
Immunochemistry Labfax
R Thorpe, B Rafferty |
Immunochemistry Labfax | 1994 |
Platelet function defects associated with hemorrhage or thrombosis
RL Bick |
Medical Clinics of North America | 1994 |
Deep vein thrombosis: Diagnosis and Management
WF Baker, RL Bick |
Medical Clinics of North America | 1994 |
Prophylaxis for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty. A Comparison between Unfractionated and Low-Molecular-Weight Heparin:
P Fauno, O Suomalainen, V Rehnberg, TB Hansen, K Kroner, S Soimakallio, E Nielsen |
The Journal of Bone and Joint Surgery. American volume. | 1994 |
Pharmacology of Current and Future Antithrombotic Therapies
TH Müller, K Binder, BD Guth |
Cardiology Clinics | 1994 |
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association
J Hirsh, V Fuster |
Circulation | 1994 |
Anticoagulation
C Doutremepuich |
1994 | |
The Modern Era of Coronary Thrombolysis
RC Becker |
1994 | |
Parnaparin: A Review of its Pharmacology, and Clinical Application in the Prevention and Treatment of Thromboembolic and Other Vascular Disorders
JE Frampton, D Faulds |
Drugs | 1994 |
Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: A clinical study
JW Borowiec, A Bylock, J der Linden, S Thelin |
The Annals of Thoracic Surgery | 1993 |
Heparin-Associated Thrombocytopenia: No Association of Immune Response with HLA
A Greinacher, G Mueller-Eckhardt |
Vox Sanguinis | 1993 |
Heparin-induced thrombocytopenia in children
IA Murdoch, RM Beattie, DM Silver |
Acta Paediatrica | 1993 |
Structural characterization of heparin's binding domain for human platelets
Y Suda, D Marques, JC Kermode, S Kusumoto, M Sobel |
Thrombosis Research | 1993 |
Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC) - a multicenter co-operative double-blind trial in comparison with heparin -
N Sakuragawa, H Hasegawa, M Maki, M Nakagawa, M Nakashima |
Thrombosis Research | 1993 |
Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery
MJ Koza, HL Messmore, ME Wallock, JM Walenga, R Pifarre |
Thrombosis Research | 1993 |
Comparison of the antithrombotic effects of low molecular weight heparinoid KB-101 and heparin in a rat experimental model
A Suehiro, J Imaoka, E Kakishita |
General Pharmacology: The Vascular System | 1993 |
Effects of Heparin on the Vessel Wall and Blood Cellular Elements
D Bergqvist, A Siegbahn |
1993 | |
The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force
BT Colvin, TW Barrowcliffe |
Journal of clinical pathology | 1993 |
Test Procedures for the Blood Compatibility of Biomaterials
S Dawids |
1993 | |
The Role of Platelets in Blood-Biomaterial Interactions
YF Missirlis, JL Wautier |
1993 | |
High-dose heparin suppresses platelet alpha granule secretion
MJ Rohrer, AS Kestin, PA Ellis, MR Barnard, L Rodino, WL Breckwoldt, JM Li, AD Michelson |
Journal of Vascular Surgery | 1992 |
Low molecular weight heparin for hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation
PE Drakos, A Nagler, R Or, S Gillis, S Slavin, A Eldor |
Cancer | 1992 |
Future alternatives to heparin: Low-molecular-weight heparin and hirudin
CE Donayre, K Ouriel, RY Rhee, CK Shortell |
Journal of Vascular Surgery | 1992 |
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
MT Nurmohamed, HR Buller, E Dekker, DW Hommes, FR Rosendaal, E Briet, FR Rosendaal, JP Vandenbroucke |
The Lancet | 1992 |
Effect of heparin and enoxaparin on platelet interaction with fibrin clots
M Mirshahi, J Soria, E Neuhart, PG Steg, P Jacob, S Combe, C Soria |
Thrombosis Research | 1992 |
The effect of heparin versus citrate on blood echogenicity in vitro: The role of platelet and platelet-neutrophil aggregates
C Mahony, J Ferguson |
Ultrasound in Medicine & Biology | 1992 |
Thrombin antagonists and antiplatelet agents
RC Becker |
The American Journal of Cardiology | 1992 |
Conjunctive antithrombotic and thrombolytic therapy for acute myocardial infarction
HJ Rapold, D Collen |
Fibrinolysis | 1992 |
Acquired Platelet Function Defects
RL Bick |
Hematology/Oncology Clinics of North America | 1992 |
Antithrombotic efficacy of low-molecular-weight heparin in deep arterial injury
M Heras, JH Chesebro, MW Webster, JS Mruk, DE Grill, V Fuster |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |
Applied Therapeutics
MA Koda-Kimble, LY Young |
1992 | |
Heparin-induced thrombocytopenia and thrombosis: Reversal with streptokinase a case report and review of literature
DP Mehta, EL Yoder, J Appel, KL Bergsman |
American Journal of Hematology | 1991 |
Heparin-induced thrombocytopenia and thrombosis with spinal ischaemia — recovery of platelet count following a change to a low molecular weight heparin
N Maurin, R Biniek, B Heintz, H Kierdorf |
Intensive Care Medicine | 1991 |
Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients
M Kuźnifwski, W Sułowicz, J Lisiewicz |
International Urology and Nephrology | 1991 |
Drug-induced Immune Thrombocytopenia
BH Chong |
Platelets | 1991 |
Low dose heparin therapy: In vitro verification of antithrombotic effect
RY Rhee, CE Donayre, K Ouriel, DG Neschis, CK Shortell |
Journal of Vascular Surgery | 1991 |
Synthesis and antithrombogenicity of heparinized polyurethanes with intervening spacer chains of various kinds
LS Liu, Y Ito, Y Imanishi |
Biomaterials | 1991 |
Platelet Function in Uraemia
MP Gordge, GH Neild |
Platelets | 1991 |
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis
PA Rowlings, R Mansberg, MC Rozenberg, S Evans, B Murray |
Australian and New Zealand Journal of Medicine | 1991 |
Heparin
JA Oates, AJ Wood, J Hirsh |
New England Journal of Medicine | 1991 |
Comparative effects of heparin and LMW heparin on hemostasis
J Hirsh, MR Buchanan |
Thrombosis Research | 1991 |
Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers
J Chen, KE Karlberg, C Sylvén |
Thrombosis Research | 1991 |
Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis
J Hirsh |
The American Journal of Surgery | 1991 |
Systemic mast cell disease associated with primary mediastinal germ cell tumor
P Chariot, I Monnet, F Lelong, C Chleq, JP Droz, H Cremoux |
The American Journal of Medicine | 1991 |
Recombinant tissue-type plasminogen activator: Current concepts and guidelines for clinical use in acute myocardial infarction. Part II
RC Becker, R Harrington |
American Heart Journal | 1991 |
Newer concepts in the treatment of unstable angina pectoris
D Waters, J Lam, P Théroux |
The American Journal of Cardiology | 1991 |
Pro: Desmopressin is of value in the treatment of post-cardiopulmonary bypass bleeding
JS Shiffrin, DD Glass |
Journal of Cardiothoracic and Vascular Anesthesia | 1991 |
Heparinized Polyurethane Surface through Ionic Bonding of Heparin
R Barbucci, A Magnani, A Albanese, F Tempesti |
The International Journal of Artificial Organs | 1991 |
Blood Use in Cardiac Surgery
N Friedel, R Hetzer, D Royston |
1991 | |
Recent Developments in Toxicology: Trends, Methods and Problems
PL Chambers, CM Chambers, WD Wiezorek, S Golbs |
1991 | |
Supported Complex and High Risk Coronary Angioplasty
FA Shawl |
1991 | |
Perinatal Thrombosis and Hemostasis
S Suzuki, WE Hathaway, J Bonnar, AH Sutor |
1991 | |
The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
W Dietrich, M Spannagl, W Schramm, W Vogt, A Barankay, JA Richter |
The Journal of Thoracic and Cardiovascular Surgery | 1991 |
Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients
LI Iverson, FG Duhaylongsod, JN Young, RR Ecker, CL Ennix, RL Moretti, M Farrar, R Hayes, J Lee, IA May |
Cardiovascular Drugs and Therapy | 1990 |
The effect of molecular weight on heparin binding to platelets
MD Horne, ES Chad |
British Journal of Haematology | 1990 |
Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin
K Krupinski, M Basic-Micic, E Lindhoff, HK Breddin |
Blut | 1990 |
Pathophysiology of Cardiopulmonary Bypass: Current Issues
JR Utley |
Journal of Cardiac Surgery | 1990 |
Arteriosklerose
A Maelicke |
Nachrichten aus Chemie, Technik und Laboratorium | 1990 |
Heparin-induced platelet aggregation. II. Dose/response relationships for two low molecular weight heparin fractions (CY 216 and CY 222)
LD Brace, J Fareed |
Thrombosis Research | 1990 |
The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and βTG/PF4 release
E Cofrancesco, M Colombi, F Gianese, M Cortellaro |
Thrombosis Research | 1990 |
The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model
T Tanaka, T Tsujinaka, J Kambayashi, M Higashiyama, M Yokota, M Sakon, T Mori |
Thrombosis Research | 1990 |
Clinical experience with low molecular weight heparins
GG Nenci, G Agnelli |
Thrombosis Research | 1990 |
Thrombocytopenia in the critically ill patient
DL Bogdonoff, ME Williams, DJ Stone |
Journal of Critical Care | 1990 |
2 Mechanisms of action of low molecular weight heparins and heparinoids
FA Ofosu, TW Barrowcliffe |
Baillière's Clinical Haematology | 1990 |
White clot syndrome: A serious complication of heparin therapy
JC Chang |
Postgraduate Medicine | 1990 |
Platelet Inhibitor Therapy: Agents and Clinical Implications
MW Webster, JH Chesebro, V Faster |
Hematology/Oncology Clinics of North America | 1990 |
Heparin and Platelets
TE Warkentin, JG Kelton |
Hematology/Oncology Clinics of North America | 1990 |
Dose- and shear rate-dependent effects of heparin on thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood
W Inauen, HR Baumgartner, T Bombeli, A Haeberli, PW Straub |
Arteriosclerosis (Dallas, Tex.) | 1990 |
Heparin: What Is It? How Does It Work?
BS Schwartz |
Clinical Cardiology | 1990 |
Unstable Angina
W Bleifeld, CW Hamm, E Braunwald |
1990 | |
Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin
K Krupinski, M Basic-Micic, E Lindhoff, HK Breddin |
Blut Zeitschrift für die Gesamte Blutforschung | 1990 |
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins:
M Verstraete |
Drugs | 1990 |
Platelet inhibitor agents in cardiovascular disease: An update
B Stein, V Fuster, DH Israel, M Cohen, L Badimon, JJ Badimon, JH Chesebro |
Journal of the American College of Cardiology | 1989 |
The mechanism of heparin-induced platelet aggregation
BH Chong, F Ismail |
European Journal of Haematology | 1989 |
Heparin-induced thrombocytopenia
BH Chong, MC Berndt |
Blut | 1989 |
In vitro platelet interactions with a heparin-polyvinyl alcohol hydrogel
CH Cholakis, MV Sefton |
Journal of Biomedical Materials Research | 1989 |
Platelet adhesion onto protein-coated and uncoated polyetherurethaneurea having tertiary amino groups in the substituents and its derivatives
Y Ito, M Sisido, Y Imanishi |
Journal of Biomedical Materials Research | 1989 |
A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery
RA Steiner, K Keller, T L�scher, WE Schreiner |
Archives of Gynecology and Obstetrics | 1989 |
Comparison of Antiplatelet Aggregatory and Antithrombotic Activity of Low Molecular Weight RD Heparin with Heparin
RL Fenichel, W Carmint, B Small, J Willis |
Annals of the New York Academy of Sciences | 1989 |
Thromboembolic problems in pregnancy
IA Greer |
Fetal and Maternal Medicine Review | 1989 |
PROTEIN C DEFICIENCY AND THROMBOTIC COMPLICATIONS AFTER LIVER TRANSPLANTATION IN CHILDREN
MD Stringer, E Melissari, VV Kakkar, KC Tan |
The Lancet | 1989 |
The ex Vivo Correlate of the Antithrombotic Action of Heparin
HC Hemker, S Béguin, J Pieters, T Lindhout |
Annals of the New York Academy of Sciences | 1989 |
Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers
JC Stiekema, HP Wijnand, TG van Dinther, HC Moelker, J Dawes, A Vinchenzo, H Toeberich |
British Journal of Clinical Pharmacology | 1989 |
Measuring platelet function with platelet shape change, an early event in aggregation
DO Beaumont, KW Whitten, RG Mock, CW Slattery |
Thrombosis Research | 1989 |
Phlegmasia Cerulea Dolens and Its Association with Hypercoagulable States: Case Reports
DJ Cohen, R Briggs, HD Head, CW Acher |
Angiology | 1989 |
Effects of Glycosaminoglycans and Protamine Chloridrate on Platelet Aggregation Induced by Collagen and Thrombin
G Luzzatto, R Paolini, F Stevanato, P Simioni, G Cella |
Angiology | 1989 |
Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy
CW White |
Circulation | 1989 |
Preservation and structural adaptation of endothelium over experimental foam cell lesions. Quantitative ultrastructural study
KE Taylor, S Glagov, CK Zarins |
Arteriosclerosis (Dallas, Tex.) | 1989 |
Heparin-induced thrombocytopenia
BH Chong, MC Berndt |
Blut Zeitschrift für die Gesamte Blutforschung | 1989 |
A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery
RA Steiner, K Keller, T Lscher, WE Schreiner |
Archives of Gynecology and Obstetrics | 1989 |
Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction
S Sherry |
Journal of the American College of Cardiology | 1988 |
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration
J Schrader, W Stibbe, VW Armstrong, M Kandt, R Muche, H Köstering, D Seidel, F Scheler |
Kidney International | 1988 |
Impairment of primary haemostasis by low molecular weight heparins in rats
A Borowska, D Lauri, A Maggi, E Dejana, G Gaetano, MB Donati, J Pangrazzi |
British Journal of Haematology | 1988 |
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
A Encke, K Breddin |
British Journal of Surgery | 1988 |
Clinical studies with low-molecular-weight heparin(oid)s: An interim analysis
HT Gate, CP Henny, JW Cate, HR Büller |
American Journal of Hematology | 1988 |
Heparin therapy for venous thrombosis and pulmonary embolism
GE Raskob, RD Hull, CJ Carter |
Blood Reviews | 1988 |
In vitro platelet adhesion and in vivo antithrombogenicity of heparinized polyetherurethaneureas
Y Ito, Y Imanishi |
Biomaterials | 1988 |
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone
SR Hanson, LA Harker |
Proceedings of the National Academy of Sciences | 1988 |
Characterization of platelet binding of heparins and other glycosaminoglycans
M Sobel, B Adelman |
Thrombosis Research | 1988 |
Heparin binding to normal and abnormal platelets
MD Horne |
Thrombosis Research | 1988 |
Observations on human platelet aggregation in native whole blood: Synergism and sensitivity to aggregating agents in vitro
DG Boyd, RB Davis |
Thrombosis Research | 1988 |
Potentiation of platelet interaction with collagen substrates by heparin is insensitive to aspirin
AV Mazurov, VE Sinitsyn, VS Repin |
Thrombosis Research | 1988 |
Heparin-Induced Thrombocytopenia and Thrombosis in Ischemic Stroke
JL Atkinson, TH SUNDT, FJ Kazmier, EW Bowie, JP Whisnant |
Mayo Clinic Proceedings | 1988 |
The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
AM Frydman, L Bara, YH Roux, M Woler, F Chauliac, MM Samama |
The Journal of Clinical Pharmacology | 1988 |
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
P Théroux, H Ouimet, J McCans, JG Latour, P Joly, G Lévy, E Pelletier, M Juneau, J Stasiak, P deGuise, GB Pelletier, D Rinzler, DD Waters |
New England Journal of Medicine | 1988 |
Thrombocytopenia and Drugs
P Handagama, BF Feldman |
Veterinary Clinics of North America Small Animal Practice | 1988 |
Importance of adequate heparin dosage in arterial angioplasty in a porcine model
M Heras, JH Chesebro, WJ Penny, KR Bailey, JY Lam, DR Holmes, GS Reeder, L Badimon, V Fuster |
Circulation | 1988 |
Haemodialysis
GR Catto |
1988 | |
Platelet-Vessel Wall Interactions
RM Pittilo, SJ Machin |
1988 | |
Acquired Disorders of Platelet Functionb
LA Harker |
Annals of the New York Academy of Sciences | 1987 |
Drug-mediated thrombocytopenia
MC Berndt, PA Castaldi |
Blood Reviews | 1987 |
Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function
DA Yardumian, K O'Flynn, DC Linch, SJ Machin |
British Journal of Haematology | 1987 |
Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)
MA Barradas, DP Mikhailidis, O Epemolu, JY Jeremy, V Fonseca, P Dandona |
British Journal of Haematology | 1987 |
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges
JM Walenga, M Petitou, JC Lormeau, M Samama, J Fareed, J Choay |
Thrombosis Research | 1987 |
A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin
E Nakanishi, H Sato, A Nakajima |
Journal of Biomedical Materials Research | 1987 |
Acute Thrombocytopenia and Thrombosis
JG Kelton, WG Murphy |
Annals of the New York Academy of Sciences | 1987 |
Effect of heparin on platelet count and platelet aggregation
AM Shojania, G Turnbull |
American Journal of Hematology | 1987 |
Thromboresistance of bulk heparinized catheters in human
R Eloy, J Belleville, J Paul, C PusinÉri, J Baguet, MC Rissoan, D Cathignol, P Ffrench, D Ville, M Tartullier |
Thrombosis Research | 1987 |
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
DB Cines, A Tomaski, S Tannenbaum |
New England Journal of Medicine | 1987 |
A 51-year-old man requires a heart transplant using cardiopulmonary bypass and has a heparin-related immune thrombocytopenia
MB Howie, GJ Suntay, DP Myerowitz, TA Galbraith, JT Brandt, VP Addonizio, N Ellison |
Journal of Cardiothoracic Anesthesia | 1987 |
Antithrombogenic Heparin-Bound Polyurethanes
Y Ito |
Journal of Biomaterials Applications | 1987 |
Heparinization of Medical Grade Polyurethanes
R Eloy, J Belleville, MC Rissoan, J Baguet |
Journal of Biomaterials Applications | 1987 |
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty
ES Barnathan, JS Schwartz, L Taylor, WK Laskey, JP Kleaveland, WG Kussmaul, JW Hirshfeld |
Circulation | 1987 |
Prostacyclin and Its Stable Analogue Iloprost
RJ Gryglewski, G Stock |
1987 | |
Cerebral Ischemia and Hemorheology
A Hartmann, W Kuschinsky |
1987 | |
Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study
Y Huet, M Gouault-Heilmann, G Contant, C Brun-Buisson |
Intensive Care Medicine | 1987 |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets
R Mastacchi, M Barbanti, P Bianchini, B Osima |
Agents and Actions | 1986 |
Drug-induced thrombocytopenia
PJ Handagama, BF Feldman |
Veterinary Research Communications | 1986 |
Pharmacology of platelet inhibitors
LA Harker, V Fuster |
Journal of the American College of Cardiology | 1986 |
The haemorrhagic and antithrombotic effects of dermatan sulphate
F Fernandez, JV Ryn, FA Ofosu, J Hirsh, MR Buchanan |
British Journal of Haematology | 1986 |
Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia
SL Pfueller, R David |
British Journal of Haematology | 1986 |
Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes
Y Ito, M Sisido, Y Imanishi |
Journal of Biomedical Materials Research | 1986 |
In vitro bioactivity of a synthesized prostaglandin E1-heparin conjugate
H Jacobs, SW Kim |
Journal of Pharmaceutical Sciences | 1986 |
Heparin fractions and analogues: a new therapeutic possibility for thrombosis
D Prost |
Trends in Pharmacological Sciences | 1986 |
Hemocompatible Polymers: Preparation and Properties
JE Wilson |
Polymer-Plastics Technology and Engineering | 1986 |
Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil
DR Weber, WK Nichols, SF Mohammad |
Thrombosis Research | 1986 |
Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors
B Kaiser, F Markwardt |
Thrombosis Research | 1986 |
Heparin-induced platelet aggregation: Dose/response relationships for a low molecular weight heparin derivative (pk 10169) and its subfractions
LD Brace, J Fareed |
Thrombosis Research | 1986 |
Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro
J Westwick, MF Scully, C Poll, VV Kakkar |
Thrombosis Research | 1986 |
Spontaneous platelet aggregation in heparinised blood during pregnancy
ME Burgess-Wilson, R Morrison, S Heptinstall |
Thrombosis Research | 1986 |
Aggregation of human neutrophils by heparin
ER Lazarowski, JA Santané, NH Behrens, JC Avalos |
Thrombosis Research | 1986 |
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
F Fernandez, P N'guyen, JV Ryn, FA Ofosu, J Hirsh, MR Buchanan |
Thrombosis Research | 1986 |
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (cy 216) in rabbits
C Doutremepuich, F Toulemonde, F Bousquet, F Bonini |
Thrombosis Research | 1986 |
Heparin-induced platelet aggregation and its inhibition by antagonists of the thromboxane pathway
E Cofrancesco, M Colombi, C Fowst, EM Pogliani |
Thrombosis Research | 1986 |
Anesthetics and anticoagulants used in the preparation of rat platelet-rich-plasma alter rat platelet aggregation
SD Dwyer, KM Meyers |
Thrombosis Research | 1986 |
Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin
K Jaschonek, C Faul, W Daiss, H Weisenbergerl |
Prostaglandins, Leukotrienes and Medicine | 1986 |
Fibrin formation and platelet aggregation in patients with acute myocardial infarction: Effects of intravenous and subcutaneous low-dose heparin
A Gallino, A Haeberli, T Hess, G Mombelli, PW Straub |
American Heart Journal | 1986 |
Low-Molecular-Weight Heparin
EW Salzman |
New England Journal of Medicine | 1986 |
Clinical Efficacy of Heparin Fractions: Issues and Answers
HL Messmore, J Hirsh |
Critical Reviews in Clinical Laboratory Sciences | 1986 |
Heparin: Do We Understand Its Antithrombotic Actions?
DB Cines |
Chest | 1986 |
Case Report: Treatment of Silastic Catheter-Induced Central Vein Septic Thrombophlebitis
MS Topiel, RT Bryan, CM Kessler, GL Simon |
The American Journal of the Medical Sciences | 1986 |
Low Molecular Weight Heparins and Heparinoid, a Recent Development in Anticoagulant Treatment: Application in Hemodialysis
JW Cate, JM Wilmink |
The International Journal of Artificial Organs | 1986 |
Thrombosis and Thrombolysis
EI Chazov, VN Smirnov |
1986 | |
Interactions of platelets with standard heparin and low molecular weight fractions
C Soria, J Soria, FW Dunn, A Thomaidis, G Tobelem, JP Caen |
The Medical Journal of Australia | 1986 |
Heparin‐induced thrombocytopenia
D Green |
The Medical Journal of Australia | 1986 |
Heparin‐like substances: acidic mucopolysaccharides from sea cucumbers and their biological effects
C Ruan, Q Wu, Z Wang, J Soria, C Soria, JP Caen |
The Medical Journal of Australia | 1986 |
Anwendung von niedermolekularem Heparin bei Hämodialysepatienten
J Schrader, J Rieger, H Müschen, W Stibbe, H Köstering, P Kramer, F Scheler |
Klinische Wochenschrift | 1985 |
Low molecular weight heparin in hemodialysis and hemofiltration patients
J Schrader, R Valentin, HJ Tönnis, U Hildebrand, W Stibbe, VW Armstrong, M Kandt, H Köstering, E Quellhorst |
Kidney International | 1985 |
Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): Studies on mechanism
SR Saba, HI Saba |
American Journal of Hematology | 1985 |
Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease
DP Mikhailidis, MA Barradas, JY Jeremy, L Gracey, A Wakeling, P Dandona |
European Journal of Clinical Investigation | 1985 |
Blood compatibility of heparinized polyurethanes
PW Heyman, SW Kim |
Die Makromolekulare Chemie | 1985 |
Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study
VV Kakkar, WJ Murray |
British Journal of Surgery | 1985 |
Complications of heparin administration in normal individuals
KA Schwartz, G Royer, DB Kautman, JA Penner |
American Journal of Hematology | 1985 |
Monomeric and Polymeric Collagen-Induced Platelet Aggregation in Citrated and Heparinized Platelet-Rich Plasma
G Csako, EA Suba, A Herp |
Connective Tissue Research | 1985 |
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway
LD Brace, S Issleib, J Fareed |
Thrombosis Research | 1985 |
Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets
A Fortini, PA Modesti, R Abbate, GF Gensini, GG Serneri |
Thrombosis Research | 1985 |
Anticoagulant effects of a low molecular weight heparinoid (ORG 10172) in human volunteers and haemodialysis patients
H Cate, CP Henny, JW Cate, HR Büller, MC Mooy, S Surachno, JM Wilmink |
Thrombosis Research | 1985 |
Hemodialysis-associated platelet activation and thrombocytopenia
RM Hakim, AI Schafer |
The American Journal of Medicine | 1985 |
Small heparin fragments regulate the amplification pathway of complement
MD Sharath, ZM Merchant, YS Kim, KG Rice, RJ Linhardt, JM Weiler |
Immunopharmacology | 1985 |
Modifications hématologiques induites par la circulation extracorporelle
A Watel, D Mathieu, A Pol, P Dequiedt, G Soots, A Cosson |
Annales Françaises d’Anesthésie et de Réanimation | 1985 |
Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weight
HP Erke |
International Journal of Immunopharmacology | 1985 |
In vivo activity of a new heparinoid
PA Ockelford, CJ Carter, J Hirsh |
Pathology | 1985 |
The heparin induced thrombosis — thrombocytopenia syndrome (H.I.T.T.S.): A review
CK Arthur, JP Isbister, EM Aspery |
Pathology | 1985 |
Heparin: Applications and Future Prospects
D Quick, AA Trowbridge |
Chest | 1985 |
Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis
U Schmitz-Huebner, H Bünte, G Freise, B Reers, C Rüschemeyer, R Scherer, H Schulte, J Loo |
Klinische Wochenschrift | 1984 |
Mechanism and characteristics of platelet activation by haematin
SM Neely, DV Gardner, N Reynolds, D Green, C Tšao |
British Journal of Haematology | 1984 |
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease
H Ten, CP Henny, HR B�ller, JW Ten, HN Magnani |
Annals of Neurology | 1984 |
Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells
JJ Castellot, MJ Karnovsky, DL Beeler, RD Rosenberg |
Journal of Cellular Physiology | 1984 |
Effects of low-molecular-weight heparin on platelets as compared with commercial heparin
G Cella, N Scattolo, G Luzzatto, A Girolami |
Research in Experimental Medicine | 1984 |
Effect of heparin on platelet aggregation
HI Saba, SR Saba, GA Morelli |
American Journal of Hematology | 1984 |
Interactions of human platelets with insoluble anticoagulant modified polystyrene resins
C Fougnot, J Lindon, L Kirshner, EW Sajzman, M Jopzefowicz |
Biomaterials | 1984 |
Interaction of antithrombin III with preadsorbed albumin-heparin conjugates
WE Hennink, CD Ebert, SW Kim, W Breemhaar, A Bantjes, J Feijen |
Biomaterials | 1984 |
Increased sensitivity of arachidonic acid-induced platelet aggregation in the presence of carbon dioxide
PJ Kerry, CJ Paton |
British Journal of Pharmacology | 1984 |
Appearance of platelet-clumping activity in heparinized plasma after acidification — it's mainly due to aggregation of fibrinogen
N Yamamoto, K Tanoue, H Yamazaki |
Thrombosis Research | 1984 |
Platelet activation caused by cardiac catheter blood collection, and its prevention
M J.Mant, C T.Kappagoda, R F.Taylor, J E.Quinlan |
Thrombosis Research | 1984 |
In vitro evaluation of a biologic graft surface. Effect of treatment with conventional and low molecular weight (LMW) heparin
CG Björck, D Bergövist, CO Esquivel, R Larsson, Y Rudsvik |
Thrombosis Research | 1984 |
A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation
JF Cade, MR Buchanan, B Boneu, P Ockelford, CJ Carter, AL Cerskus, J Hirsh |
Thrombosis Research | 1984 |
THE THROMBORESISTANCE OF A HEPARIN-POLYVINYL ALCOHOL HYDROGEL†
MV Sefton, WF Ip, G Rollason, MW Hatton, W Zingg |
Chemical Engineering Communications | 1984 |
Structural studies on heparin. Tetrasaccharides obtained by heparinase degradation
A Linker |
Carbohydrate Research | 1984 |
Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism
RB Stead, AI Schafer, RD Rosenberg, RI Handin, M Josa, SF Khuri |
The American Journal of Medicine | 1984 |
Thrombocytopenia in a Prospective, Randomized, Double-Blind Trial of Bovine and Porcine Heparin
D Green, GJ Martin, SH Shoichet, N Debacker, JS Bomalaski, RN Lind |
The American Journal of the Medical Sciences | 1984 |
Heparin-Induced Thrombocytopenia-Association with a Platelet Aggregating Factor and Cross-Sensitivity to Bovine and Porcine Heparin
DR Guay, A Richard |
1984 | |
Controlling Anticoagulation in Extracorporeal Blood Circuits (hemoperfusion)
L Mor, S Sideman, M Mihich, A Tzipiniuk, S Lupovich, JM Brandes |
The International Journal of Artificial Organs | 1984 |
Effect of heparin bonding on catheter-induced fibrin formation and platelet activation
AB Nichols, J Owen, BA Grossman, JJ Marcella, LN Fleisher, MM Lee |
Circulation | 1984 |
Biomaterials in Artificial Organs
JP Paul, JD Gaylor, JM Courtney, T Gilchrist |
1984 | |
Technical Considerations for Platelet Aggregation and Related Problems
ML Tiffany, RL Henry |
Critical Reviews in Clinical Laboratory Sciences | 1983 |
ASPIRIN PREVENTS HEPARIN-INDUCED PLATELET AGGREGATION IN VIVO
PA Janson, JL Moake, G Carpinito |
British Journal of Haematology | 1983 |
Normal and low molecular weight heparins: interaction with human platelets
F Fabris, F Fussi, A Casonato, L Visentin, M Randi, MR Smith, A Girolami |
European Journal of Clinical Investigation | 1983 |
Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation
MS Cairo, J Allen, C Higgins, RL Baehner, LA Boxer |
The American Journal of Pathology | 1983 |
The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat
HR Büller, PM Hobbelen, AW Princen, HC Moelker, JW Cate |
Thrombosis Research | 1983 |
Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously
D Bergqvist, U Hedner, E Sjörin, E Holmer |
Thrombosis Research | 1983 |
Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate
F Dunn, J Soria, C Soria, A Thomaidis, G Tobelem, JP Caen |
Thrombosis Research | 1983 |
Myocardial Infarction and Cardiac Death
WH Frishman, EH Sonnenblick |
Myocardial Infarction and Cardiac Death | 1983 |
Biology and therapeutic potential of prostacyclin
S Moncada |
Stroke; a journal of cerebral circulation | 1983 |
Thrombocytopenia Due to Non-immune Platelet Destruction
JM Harlan |
Clinics in Haematology | 1983 |
Acquired Qualitative Platelet Disorders
AK Rao, PN Walsh |
Clinics in Haematology | 1983 |
How safe is heparin?
WR Pitney |
The Medical Journal of Australia | 1983 |
HEPARIN-INDUCED THROMBOCYTOPENIA: ASSOCIATION OF THROMBOTIC COMPLICATIONS WITH HEPARIN-DEPENDENT IgG ANTIBODY THAT INDUCES THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION
BH Chong, WR Pitney, PA Castaldi |
The Lancet | 1982 |
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin
S Moncada |
British Journal of Pharmacology | 1982 |
Immobilized heparin: Spacer arm effects on biological interactions
CD Ebert, KS Wan |
Thrombosis Research | 1982 |
Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde
JA Davies, VC Menys |
Thrombosis Research | 1982 |
Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions
MG Huisse, MC Guillin, A Bezeaud, F Toulemonde, M Kitzis, B Andreassian |
Thrombosis Research | 1982 |
Interaction of heparin and heparin fractions with human platelets
R Mastacchi, L Stanzani, M Barbanti, L Montecchi, P Bianchini |
Thrombosis Research | 1982 |
A low molecular weight heparin compared with unfractionated heparin
DP Thomas, RE Merton |
Thrombosis Research | 1982 |
A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models
DG Meuleman, PM Hobbelen, G Dedem, HC Moelker |
Thrombosis Research | 1982 |
On the mechanism of heparin-induced potentiation of platelet aggregation
M Yamamoto, K Watanabe, Y Ando, H Iri, H Handa, Y Yoshii, M Imai, K Sugiura, Y Ikeda |
Thrombosis Research | 1982 |
Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction
PA Ockelford, CJ Carter, A Cerskus, CA Smith, J Hirsh |
Thrombosis Research | 1982 |
Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo
CO Esquivel, D Bergqvist, CG Björck, B Nilsson |
Thrombosis Research | 1982 |
Potentiation of endoperoxide analog-induced platelet aggregation by heparin
P Mehta, J Mehta |
Thrombosis Research | 1982 |
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
S Moncada |
British Journal of Pharmacology | 1982 |
Prostacyclin substitution for heparin in long-term hemodialysis
MC Smith, K Danviriyasup, JW Crow, AE Cato, GD Park, A Hassid, MJ Dunn |
The American Journal of Medicine | 1982 |
Biochemical Immunological Pharmacology
PE Lipsky |
Biochemical Immunological Pharmacology | 1982 |
Pathobiology of the Endothelial Cell
SA Stalcup, GM Turino, RB Mellins |
Pathobiology of the Endothelial Cell | 1982 |
Fulminant hepatic failure and artificial liver support
AE Gimson, R Ede, S Braude, RD Hughes, PJ Langley, R Williams |
Gastroenterologia Japonica | 1982 |
Fortschritte in der Kardiologie
W Schaper, MG Gottwik |
1982 | |
Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 Convertase
MD Kazatchkine, DT Fearon, DD Metcalfe, RD Rosenberg, KF Austen |
Journal of Clinical Investigation | 1981 |
In vitro Methods and the Study of Platelet Mechanisms
MA Packham, JF Mustard |
Vox Sanguinis | 1981 |
HEPARIN AND OTHER SULFATED POLYANIONS: THEIR INTERACTION WITH THE BLOOD PLATELET*
ML Tiffany, JA Penner |
Annals of the New York Academy of Sciences | 1981 |
Patency of Heparinized SBS Shunts at High Shear Rates
MV Sefton, W Zingg |
Artificial Cells, Blood Substitutes and Biotechnology | 1981 |
Thrombosis: its role and prevention in cardiovascular events--Part I. Concepts of thrombogenesis and its prevention
LA Harker |
The Western journal of medicine | 1981 |
Disorders of platelet function: mechanisms, diagnosis and management
LB Huebsch, LA Harker |
The Western journal of medicine | 1981 |
Immunoglobulin-sulfated polysaccharide interactions. Binding of agaropectin and heparin by human IgG proteins
DE Levy, AA Horner, A Solomon |
Journal of Experimental Medicine | 1981 |
Inhibition of platelet activation by prostacyclin: Possible consequences in coagulation and anticoagulation
S Bunting, PM Simmons, S Moncada |
Thrombosis Research | 1981 |
Platelet reactivity in patients with degenerated porcine bioprosthetic valves
JM Riddle, DJ Magilligan, PD Stein |
Thrombosis Research | 1981 |
Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation
DE MacIntyre, RI Handin, R Rosenberg, EW Salzman |
Thrombosis Research | 1981 |
Heparinized Polymers as Thromboresistant Biomaterials
JE Wilson |
Polymer-Plastics Technology and Engineering | 1981 |
A comparison of prostacyclin and heparin on hemodialyses in dogs
M Gross, H Bush, H McTigue, RJ Hamburger, W Flamenbaum |
Prostaglandins | 1981 |
Prostacyclin and Blood Coagulation:
S Moncada, JR Vane |
Drugs | 1981 |
THROMBOSIS AND THROMBOCYTOPENIA INDUCED BY HEPARIN
L Carreras |
Scandinavian Journal of Haematology | 1980 |
EDITORIAL
IW Percy-Robb, ND Finlayson, MF Oliver |
European Journal of Clinical Investigation | 1980 |
Inactivation of thrombin by antithrombin III on a heparinized biomaterial
MF Goosen, MV Sefton, MW Hatton |
Thrombosis Research | 1980 |
Heparin-Associated Thrombocytopenia
DB Cines, P Kaywin, M Bina, A Tomaski, AD Schreiber |
New England Journal of Medicine | 1980 |
Heparin-Associated Thrombocytopenia: A Comparison of Three Heparin Preparations
WR Bell, RM Royall |
New England Journal of Medicine | 1980 |
Pulmonary thromboembolism: 2. New trends in prophylaxis and therapy
JC Giudice, HJ Komansky, J Kaufman |
Postgraduate Medicine | 1980 |
Clinical Pharmacology & Therapeutics
P Turner, C Padgham, A Hedges |
Clinical Pharmacology & Therapeutics | 1980 |
Antithrombotic Drugs in Relation to Prostaglandin Metabolism
J Ogrady, S Bunting, S Moncada |
Clinics in Haematology | 1980 |
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher |
1979 | |
Annotation
B Bennett |
British Journal of Haematology | 1974 |
Prostaglandins and the Kidney
JC Mcgiff, HD ITSKOVITZ |
Circulation research | 1973 |
Hematology
JJ Shea, JJ Shea |
The Laryngoscope | 1949 |